These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7652784)

  • 21. Interferon-alpha therapy for chronic hepatitis C in special patient populations.
    Marcellin P; Boyer N; Behamou JP; Erlinger S
    Dig Dis Sci; 1996 Dec; 41(12 Suppl):126S-130S. PubMed ID: 9011470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-alpha 2b treatment of chronic hepatitis C in haemodialysis patients.
    Raptopoulou-Gigi M; Spaia S; Garifallos A; Xenou P; Orphanou H; Zarafidou E; Petridou P; Vrettou H; Vagionas G; Galaktidou G
    Nephrol Dial Transplant; 1995 Oct; 10(10):1834-7. PubMed ID: 8592590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of interferon alpha in acute hepatitis C in patients on chronic hemodialysis.
    Süleymanlar I; Sezer T; Işitan F; Yakupoglu G; Süleymanlar G
    Nephron; 1998; 79(3):353-4. PubMed ID: 9678442
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of pretransplant chronic hepatitis C virus infection treatment on graft and patient survival in renal transplant recipients.
    Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Ensaroğlu F; Selçuk H; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():188-92. PubMed ID: 25894152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term impact of hepatitis virus infection on kidney transplant recipients and a pilot study of the effects of interferon alpha on chronic hepatitis C.
    Hanafusa T; Ichikawa Y; Kyo M; Fukunishi T; Nagano S; Nakayama K; Nishiuchi M; Ihara H; Fujimoto N; Shinji Y
    Transplant Proc; 1995 Feb; 27(1):956-7. PubMed ID: 7533440
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hepatitis C virus infection in renal-transplant patients].
    Kamar N; Izopet J; Ribes D; Rostaing L
    Nephrologie; 2004; 25(1):9-15. PubMed ID: 15022868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa.
    Tanaka E; Kiyosawa K; Matsumoto A; Kashiwakuma T; Hasegawa A; Mori H; Yanagihara O; Ohta Y
    Hepatology; 1996 Jun; 23(6):1330-3. PubMed ID: 8675147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of hepatitis B and C in renal failure and renal transplant recipients.
    Amarapurkar D; Das HS
    Trop Gastroenterol; 2002; 23(2):49-53. PubMed ID: 12632966
    [No Abstract]   [Full Text] [Related]  

  • 29. Panel reactive antibodies in predicting hepatitis C virus treatment outcome in kidney transplant candidates.
    Öcal S; Harmancı Ö; Korkmaz M; Ensaroğlu F; Çolak T; Selçuk H; Moray G; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():193-6. PubMed ID: 25894153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment.
    Magrin S; Craxi A; Fabiano C; Simonetti RG; Fiorentino G; Marino L; Diquattro O; Di Marco V; Loiacono O; Volpes R
    Hepatology; 1994 Feb; 19(2):273-9. PubMed ID: 8294085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantation.
    Knapstein J; Galle PR; Zimmermann T
    Dig Liver Dis; 2014 Jan; 46(1):88-9. PubMed ID: 24054768
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and tolerance of interferon-alpha in the treatment of chronic hepatitis C in end-stage renal disease patients on hemodialysis.
    Rocha CM; Perez RM; Ferreira AP; Carvalho-Filho RJ; Pace FH; Silva IS; Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
    Liver Int; 2006 Apr; 26(3):305-10. PubMed ID: 16584392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand.
    Scott DR; Wong JK; Spicer TS; Dent H; Mensah FK; McDonald S; Levy MT
    Transplantation; 2010 Dec; 90(11):1165-71. PubMed ID: 20861806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-alpha retreatment in chronic hepatitis C.
    Gerken G; Teuber G; Goergen B; Meyer zum Büschenfelde KH
    J Hepatol; 1995; 22(1 Suppl):118-21. PubMed ID: 7602063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term interferon treatment of chronic delta hepatitis: a multicenter Italian study.
    Rosina F; Pintus C; Meschievitz C; Rizzetto M
    Prog Clin Biol Res; 1991; 364():385-91. PubMed ID: 2020713
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatitis C virus and nonliver solid organ transplantation.
    Carbone M; Mutimer D; Neuberger J
    Transplantation; 2013 Mar; 95(6):779-86. PubMed ID: 23172130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C infection and the patient with end-stage renal disease.
    Fabrizi F; Poordad FF; Martin P
    Hepatology; 2002 Jul; 36(1):3-10. PubMed ID: 12085342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Complete cytogenetic response to interferon-alpha in a patient with chronic myelogenous leukemia undergoing hemodialysis].
    Doi S; Edamura S; Akasaka H; Kawamura M; Arima N; Nasu K
    Rinsho Ketsueki; 2001 Jul; 42(7):549-53. PubMed ID: 11524845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon alpha 2a in patients of chronic hepatitis C.
    Zuberi SJ; Alam SE; Raza S
    J Pak Med Assoc; 1994 Jul; 44(7):171-2. PubMed ID: 7933458
    [No Abstract]   [Full Text] [Related]  

  • 40. Interferon-alpha facilitates renal transplantation in hemodialysis patients with chronic viral hepatitis.
    Duarte R; Huraib S; Said R; Abdel-Khadir A; Sullivan S; Chaballout A; Sbeih F; Mughal T
    Am J Kidney Dis; 1995 Jan; 25(1):40-5. PubMed ID: 7810531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.